Related Experiment Video

Updated: Aug 8, 2026

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
14:55

Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

Published on: May 12, 2013

Preclinical and clinical experience of antisense therapy for solid tumors

M S Webb1, G Zon

  • 1Inex Pharmaceuticals Corporation, Bumaby, BC, Canada. mwebb@inexpharm.com

Current Opinion in Molecular Therapeutics
|November 21, 2001
PubMed

Insights

Antisense drugs show promise for treating cancer by optimizing combination therapies and utilizing novel delivery systems. Further research will enhance their clinical utility and therapeutic window for improved neoplasm treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Antisense drugs offer a promising avenue for cancer treatment.
  • Optimizing their efficacy requires understanding combination therapy regimens and oncogene interactions.

Purpose of the Study:

  • To discuss the optimization of therapeutic windows and clinical utility of antisense drugs.
  • To highlight the role of combination therapy and novel delivery systems.

Main Methods:

  • Review of preclinical and clinical research on antisense oligonucleotide (ON) combination therapies.
  • Exploration of novel delivery systems, such as lipid-based carriers, for systemic delivery.

Main Results:

  • Current research focuses on defining optimal combination therapy regimens for antisense drugs (ONs).
  • Novel delivery systems are expanding the therapeutic window for antisense drugs.
  • Understanding oncogene interactions is crucial for achieving synergistic benefits.

Conclusions:

  • Antisense technology, combined with effective delivery systems, is expected to significantly improve the treatment of human neoplasms.
  • Further research into oncogene interactions and combination therapies is needed to maximize therapeutic benefits.

More Related Videos

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System07:47

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System

Published on: October 29, 2019

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...